The European Medicines Agency (EMA) recently announced that it would decide on applications from BioNTech-Pfizer and Moderna regarding their vaccines adapted for the BA.1 variant of the virus.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/EkKCnbW
0 Comments